Urinary neopterin levels in uveitis: Is it a new activity marker?

Ocular Immunology and Inflammation

Volumn 15, Issue 4, 2007, Pages 303-308

  Durukan, Ali H ^a   Hurmeric, Volkan ^a   Akgul, Emin O ^a   Kilic, Selim ^a   Bayraktar, Mehmet Z ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Disease activity; Urinary neopterin levels; Uveitis

Indexed keywords

ALPHA2A INTERFERON; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; FLUORESCEIN; MOLECULAR MARKER; NEOPTERIN;

ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE MARKER; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PROTEIN URINE LEVEL; STATISTICAL SIGNIFICANCE; UVEITIS;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MALE; NEOPTERIN; PROGNOSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX; UVEITIS, ANTERIOR;

EID: 34548303657     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940701344374     Document Type: Article

References (29)

1. Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Neopterin in clinical medicine. Lancet. 1988;8587:702.
2. Havel M, Jakovics A, Teufelsbauer H. Neopterin as a new marker to detect acute rejection after heart transplantation. J. Heart Transplant. 1989;8:67-70.
3. Fuchs D, Weiss G, Wacher H. Neopterin. Biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol. 1993;101:1-6.
4. Müller TF, Vogl M, Neumann MC, Lange H, Grimm M, Müller MM. Noninvasive monitoring using serum amyloid A and serum neopterin in cardiac transplantation. Clin Chim Acta. 1998;276:63-74.
5. Vrecko K, Staedtler P, Mischak I, Maresch L, Reibnegger G. Periodontitis and concentrations of the cellular immune activation marker neopterin in saliva and urine. Clin Chim Acta. 1997;268:31-40.
6. Fredrikson S, Link H, Eneroth P. CSF neopterin as marker of disease activity in multiple sclerosis. Acta Neurol Scand. 1987;75:352-355.
7. Murr C, Fuith LC, Widner B, Wirleitner B, Baier-Bitterlich G, Fuchs D. Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res. 1999;19:1721-1728.
8. Weiss G, Widner B, Zoller H, Schobersberger W, Fuchs D. Immune response and iron metabolism. Br J Anaesth. 1998;81:6-9.
9. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharmacol Ther. 2001;26:319-329.
10. Werner ER, Bichler A, Daxenbichler G. Determination of neopterin in serum and urine. Clin Chem. 1987;33:62-66.
11. Katoh S, Sueoka T, Matsuura S, Sugimoto T. Biopterin and neopterin in human saliva. Life Sci. 1989;54:2561-2568.
12. Furukawa Y, Nishi K, Kondo T, Tanabe K, Mizuno Y. Significance of CSF total neopterin and biopterin in inflammatory neurological diseases. J Neurol Sci. 1992;111:65-72.
13. Rao GN, Cotlier E. Biosynthesis of neopterin, sepiapterin, and biopterin in rat and human ocular tissues. Invest Ophthalmol Vis Sci. 1985;26:768-770.
14. Duch DS, Bowers SW, Woolf JH, Nichol CA. Biopterin cofactor biosynthesis. GTP cyclohydrolase, neopterin and biopterin in tissues and body fluids of mammalian species. Life Sci. 1984;35:1895-1901.
15. Kose O, Arca E, Akgul O, Erbil K. The levels of serum neopterin in Behcet's disease-objective marker of disease activity. J Dermatol Sci. 2006;42:128-130.
16. Abi-Hanna D, Wakefield D. Increased serum neopterin levels in patients with acute anterior uveitis. Curr Eye Res. 1988;7:497-502.
17. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234-235.
18. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;8697:1078-1080.
19. Fuchs D, Werner ER, Wachter H. Soluble products of immune activation: neopterin. In: Rose RR, de Macario EC, Fahey JL, Fiedman H, Denn GM, eds. Manual of Clinical Laboratory Immunology. Washington, DC: American Society of Microbiology; 1992;251-255.
20. Lightman S. Uveitis: what do we know and how does it help? Clin Exp Immunol. 2001;29:48-51.
21. De Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res. 1992;11:581-597.
22. Müller MM, Curtius HC, Herold M, Huber CH. Neopterin in clinical practice. Clin Chim Acta. 1991;201:1-16.
23. Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab. 1999;10:359-368.
24. Fuchs D, Hausen A, Kofler M, Kosanowski H, Reibnegger G, Wachter H. Neopterin as an index of immune response in patients with tuberculosis. Lung. 1991;162:337-346.
25. Reibnegger GJ, Bichler AH, Dapunt O, et al. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res. 1986;46:950-955.
26. Murr C, Bergant A, Widschwendter M, Heim K, Schrocksnadel H, Fuchs D. Neopterin is an independent prognostic variable in females with breast cancer. Clin Chem. 1999;45:1998-2004.
27. Gurfinkel EP, Scirica BM, Bozovich G, Macchia A, Manos E, Mautner B. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol. 1999;83:515-518.
28. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol. 1993;101:1-6.
29. Keser G, Oksel F, Aksu K, Kabasakal Y, Gumusdis G. Serum neopterin levels in Behcet's syndrome. Clin Rheumatol. 2000;19:328-329.